Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Azlinda Binti Ariffin-Boromand was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • May 21
Unigel Group plc, Annual General Meeting, Jun 19, 2025 Unigel Group plc, Annual General Meeting, Jun 19, 2025. Location: the offices of shakespeare martineau llp, 6th floor, 60 gracechurch street, ec3v 0hr, london United Kingdom 공시 • Jun 01
Unigel Group plc, Annual General Meeting, Jun 21, 2024 Unigel Group plc, Annual General Meeting, Jun 21, 2024. Location: the offices of shakespeare martineau llp, 6th floor, 60 gracechurch street, ec3v 0hr, london United Kingdom New Risk • May 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Shareholders have been diluted in the past year (28% increase in shares outstanding). Market cap is less than US$100m (€13.6m market cap, or US$14.8m). New Risk • Feb 20
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 28% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shares are highly illiquid. Minor Risks Shareholders have been diluted in the past year (28% increase in shares outstanding). Market cap is less than US$100m (€13.5m market cap, or US$14.6m). 공시 • Jan 25
Unigel Group plc (OFEX:UNX) agreed to acquire remaining 40% stake in UNIGEL (UK) Limited from Hextar Capital Berhad (KLSE:HEXCAP) for £1.3 million. Unigel Group plc (OFEX:UNX) agreed to acquire remaining 40% stake in UNIGEL (UK) Limited from Hextar Capital Berhad (KLSE:HEXCAP) for £1.3 million on January 23, 2024. The consideration consists of £1.30 million in cash. Prior to the transaction, Unigel Group plc (OFEX:UNX) held 60%. M & A Securities Sdn Bhd acted as a financial advisor, and Asia Equity Research Sdn. Bhd. provided the fairness opinion to Hextar. Transaction is subject to approval of Hextar shareholders.